share_log

Kezar Life Sciences Shares Up 94%; Hearing William Blair Raises Price Target To $19, Hearing Wells Fargo Raises Price Target To $17

Benzinga Real-time News ·  Jun 28, 2022 08:50
Kezar Life Sciences Shares Up 94%; Hearing William Blair Raises Price Target To $19, Hearing Wells Fargo Raises Price Target To $17
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment